Isolaz Benefits the ACNE Market

+ Expand All   - Collapse All

  • Active Acne Patients
    •   60 million Americans have active acne1
    •   85% of teenagers suffer from acne (ages 12-24)1
    •   Acne in adult women has risen in recent years
    •   #1 reason a patient goes to a dermatologist
  • Active Acne Types
    •   Mild to moderate acne, including pustular acne, comedonal
                 acne, and mild to moderate inflammatory acne (acne vulgaris)
  • All Skin Types
    •   Fitzpatrick skin types I – VI
  • Clearance
    •   Immediate impact on active lesions (24-48 hours post)2
    •   Decrease in the amount of oil production, starting
                 after the first treatment3
    •   Acne in adult women has risen in recent years
    •   Complete results in 4-6 weeks
  • Comfortable and Compliant
    •   Patients are excited to come back for Isolaz (it’s easy,
                 comfortable and gets results)
    •   Most patients experience little or no discomfort
    •   Quick, 15-30 mi   nute procedure
    •   Does not interfere with their lifestyle to ensure good
                 patient compliance
    •   Adherence to traditional therapies is typically low
  • Cash
    •   Insurance does not cover acne therapies for ages 25+
    •   Generate revenue with cash-pay procedure
    •   Short treatment courses; revenue within 6 weeks
    •   Profusion treatments allow the use of complementary topical
    •   Opportunity to develop long-term relationships with highly
                 satisfied patients to extend to other therapies and add new
                 patients (parents of teens)
  • Non-Responders to Other Treatments
    •   Treat patients who have tried everything with limited results
    •   75% improvement in patients who were non-responders to other
                 acne treatments3
  • No Systemic Side Effects
    •   Non-systemic acne solution
    •   As typically associated with other acne treatment options,
                 such as oral medications
  • No Downtime
    •   Mild redness immediately after treatment
  • Effective and Reliable
    •   FIRST choice acne therapy
    •   Maintenance treatments ensure long term clearance
  • Easy to Use and Integrate
    •   Preset treatment parameters
    •   Procedure can be delegated (dependent on local regulation)
    •   Quick turnaround time


1, American Dermatologist Association
2 Multi-Center data presented to the FDA, July 2006. Aesthera Corporation.
3Shamban, Ava T., MD. Photopneumatic (PPx) Pore-Cleansing Acne Treatment: A Breakthrough Treatment Option for Non-Responders to Acne Therapies. White Paper. August 2006